160 related articles for article (PubMed ID: 12714115)
1. Does aspirin or other NSAIDs reduce the risk of cognitive decline in elderly persons? Results from a population-based study.
Jonker C; Comijs HC; Smit JH
Neurobiol Aging; 2003; 24(4):583-8. PubMed ID: 12714115
[TBL] [Abstract][Full Text] [Related]
2. Aspirin, anti-inflammatory drugs and risk of dementia.
Henderson AS; Jorm AF; Christensen H; Jacomb PA; Korten AE
Int J Geriatr Psychiatry; 1997 Sep; 12(9):926-30. PubMed ID: 9309471
[TBL] [Abstract][Full Text] [Related]
3. Protective effect of chronic NSAID use on cognitive decline in older persons.
Rozzini R; Ferrucci L; Losonczy K; Havlik RJ; Guralnik JM
J Am Geriatr Soc; 1996 Sep; 44(9):1025-9. PubMed ID: 8790225
[TBL] [Abstract][Full Text] [Related]
4. APOE-epsilon4 is associated with memory decline in cognitively impaired elderly.
Dik MG; Jonker C; Bouter LM; Geerlings MI; van Kamp GJ; Deeg DJ
Neurology; 2000 Apr; 54(7):1492-7. PubMed ID: 10751265
[TBL] [Abstract][Full Text] [Related]
5. NSAID and aspirin use by the elderly in general practice: effect on gastrointestinal symptoms and therapies.
Pilotto A; Franceschi M; Leandro G; Di Mario F;
Drugs Aging; 2003; 20(9):701-10. PubMed ID: 12831293
[TBL] [Abstract][Full Text] [Related]
6. Stroke and apolipoprotein E epsilon4 are independent risk factors for cognitive decline: A population-based study.
Dik MG; Deeg DJ; Bouter LM; Corder EH; Kok A; Jonker C
Stroke; 2000 Oct; 31(10):2431-6. PubMed ID: 11022076
[TBL] [Abstract][Full Text] [Related]
7. Memory complaints and APOE-epsilon4 accelerate cognitive decline in cognitively normal elderly.
Dik MG; Jonker C; Comijs HC; Bouter LM; Twisk JW; van Kamp GJ; Deeg DJ
Neurology; 2001 Dec; 57(12):2217-22. PubMed ID: 11756600
[TBL] [Abstract][Full Text] [Related]
8. Aspirin use and cognitive function in the elderly.
Stürmer T; Glynn RJ; Field TS; Taylor JO; Hennekens CH
Am J Epidemiol; 1996 Apr; 143(7):683-91. PubMed ID: 8651230
[TBL] [Abstract][Full Text] [Related]
9. Nonsteroidal anti-inflammatory drugs, aspirin, and cognitive function in the Baltimore longitudinal study of aging.
Waldstein SR; Wendell CR; Seliger SL; Ferrucci L; Metter EJ; Zonderman AB
J Am Geriatr Soc; 2010 Jan; 58(1):38-43. PubMed ID: 20122039
[TBL] [Abstract][Full Text] [Related]
10. Regular use of nonsteroidal anti-inflammatory drugs and cognitive function in aging women.
Kang JH; Grodstein F
Neurology; 2003 May; 60(10):1591-7. PubMed ID: 12771247
[TBL] [Abstract][Full Text] [Related]
11. Lack of association of nonsteroidal anti-inflammatory drug use and cognitive decline in the elderly.
May FE; Moore MT; Stewart RB; Hale WE
Gerontology; 1992; 38(5):275-9. PubMed ID: 1427126
[TBL] [Abstract][Full Text] [Related]
12. Non-steroidal anti-inflammatory drug use and cervical cancer risk: a case-control study using the Clinical Practice Research Datalink.
Wilson JC; O'Rorke MA; Cooper JA; Murray LJ; Hughes CM; Gormley GJ; Anderson LA
Cancer Epidemiol; 2013 Dec; 37(6):897-904. PubMed ID: 24042024
[TBL] [Abstract][Full Text] [Related]
13. Association of aspirin and other non-steroidal anti-inflammatory drug use with incidence of non-Hodgkin lymphoma.
Cerhan JR; Anderson KE; Janney CA; Vachon CM; Witzig TE; Habermann TM
Int J Cancer; 2003 Sep; 106(5):784-8. PubMed ID: 12866040
[TBL] [Abstract][Full Text] [Related]
14. Maintenance use of aspirin or other non-steroidal anti-inflammatory drugs (NSAIDs) and prostate cancer risk.
Ma Y; Brusselaers N
Prostate Cancer Prostatic Dis; 2018 Apr; 21(1):147-152. PubMed ID: 29259292
[TBL] [Abstract][Full Text] [Related]
15. Use of nonsteroidal anti-inflammatory drugs and risk of endometrial cancer: a nationwide case-control study.
Brøns N; Baandrup L; Dehlendorff C; Kjaer SK
Cancer Causes Control; 2015 Jul; 26(7):973-81. PubMed ID: 25895439
[TBL] [Abstract][Full Text] [Related]
16. Use of aspirin and other nonsteroidal anti-inflammatory drugs and risk of esophageal and gastric cancer.
Farrow DC; Vaughan TL; Hansten PD; Stanford JL; Risch HA; Gammon MD; Chow WH; Dubrow R; Ahsan H; Mayne ST; Schoenberg JB; West AB; Rotterdam H; Fraumeni JF; Blot WJ
Cancer Epidemiol Biomarkers Prev; 1998 Feb; 7(2):97-102. PubMed ID: 9488582
[TBL] [Abstract][Full Text] [Related]
17. Use of paracetamol, low-dose aspirin, or non-aspirin non-steroidal anti-inflammatory drugs and risk of ovarian borderline tumors in Denmark.
Hannibal CG; Dehlendorff C; Kjaer SK
Gynecol Oncol; 2018 Dec; 151(3):513-518. PubMed ID: 30249529
[TBL] [Abstract][Full Text] [Related]
18. Nonsteroidal antiinflammatory drugs and cognitive decline in the elderly.
Saag KG; Rubenstein LM; Chrischilles EA; Wallace RB
J Rheumatol; 1995 Nov; 22(11):2142-7. PubMed ID: 8596158
[TBL] [Abstract][Full Text] [Related]
19. Nonsteroidal antiinflammatory drugs and the risk of myocardial infarction in the general population.
García Rodríguez LA; Varas-Lorenzo C; Maguire A; González-Pérez A
Circulation; 2004 Jun; 109(24):3000-6. PubMed ID: 15197149
[TBL] [Abstract][Full Text] [Related]
20. Effect of non-steroidal anti-inflammatory medications on the risk of amyotrophic lateral sclerosis.
Popat RA; Tanner CM; van den Eeden SK; Bernstein AL; Bloch DA; Leimpeter A; McGuire V; Nelson LM
Amyotroph Lateral Scler; 2007 Jun; 8(3):157-63. PubMed ID: 17538777
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
